Wasniewska MG - Search Results

1

Growth Hormone Treatment to Final Height in Turner Syndrome: Systematic Review.

Aversa T, Li Pomi A, Pepe G, Corica D, Messina MF, Coco R, Sippelli F, Ferraloro C, Luppino G, Valenzise M, Wasniewska MG. Aversa T, et al. Among authors: wasniewska mg. Clin Ther. 2024 Feb;46(2):146-153. doi: 10.1016/j.clinthera.2023.12.004. Epub 2023 Dec 26. Clin Ther. 2024. PMID: 38151406 Free article. Review.

2

Growth hormone deficient children treated from before two years old fail to catch-up completely within five years of therapy.

Arrigo T, Bozzola M, Cavallo L, Ghizzoni L, Maghnie M, Messina MF, Wasniewska M, De Luca F. Arrigo T, et al. J Pediatr Endocrinol Metab. 1998 Jan-Feb;11(1):45-50. doi: 10.1515/jpem.1998.11.1.45. J Pediatr Endocrinol Metab. 1998. PMID: 9642628

3

Relationships between neuroradiological and clinical features in apparently idiopathic hypopituitarism.

Arrigo T, De Luca F, Maghnie M, Blandino A, Lombardo F, Messina MF, Wasniewska M, Ghizzoni L, Bozzola M. Arrigo T, et al. Eur J Endocrinol. 1998 Jul;139(1):84-8. doi: 10.1530/eje.0.1390084. Eur J Endocrinol. 1998. PMID: 9703383

4

Birth weight influences long-term catch-up growth and height prognosis of GH-deficient children treated before the age of 2 years.

Wasniewska M, Arrigo T, Cisternino M, De Luca F, Ghizzoni L, Maghnie M, Valenzise M. Wasniewska M, et al. Eur J Endocrinol. 2000 May;142(5):460-5. doi: 10.1530/eje.0.1420460. Eur J Endocrinol. 2000. PMID: 10802522

5

Final height in isolated GH deficiency type 1A: effects of 5-year treatment with IGF-I.

Messina MF, De Luca F, Wasniewska M, Valenzise M, Lombardo F, Ghizzoni L. Messina MF, et al. Eur J Endocrinol. 2001 Apr;144(4):379-83. doi: 10.1530/eje.0.1440379. Eur J Endocrinol. 2001. PMID: 11275947

6

Three-year prospective evaluation of glucose tolerance, beta-cell function and peripheral insulin sensitivity in non-diabetic patients with thalassemia major.

Messina MF, Lombardo F, Meo A, Miceli M, Wasniewska M, Valenzise M, Ruggeri C, Arrigo T, De Luca F. Messina MF, et al. J Endocrinol Invest. 2002 Jun;25(6):497-501. doi: 10.1007/BF03345490. J Endocrinol Invest. 2002. PMID: 12109619

7

Hearing loss in congenital hypothalamic hypothyroidism: a wide therapeutic window.

Wasniewska M, De Luca F, Siclari S, Salzano G, Messina MF, Lombardo F, Valenzise M, Ruggeri C, Arrigo T. Wasniewska M, et al. Hear Res. 2002 Oct;172(1-2):87-91. doi: 10.1016/s0378-5955(02)00515-4. Hear Res. 2002. PMID: 12361870

8

Two-year prospective evaluation of the factors affecting honeymoon frequency and duration in children with insulin dependent diabetes mellitus: the key-role of age at diagnosis.

Lombardo F, Valenzise M, Wasniewska M, Messina MF, Ruggeri C, Arrigo T, De Luca F. Lombardo F, et al. Diabetes Nutr Metab. 2002 Aug;15(4):246-51. Diabetes Nutr Metab. 2002. PMID: 12416662

9

In congenital hypothyroidism bone maturation at birth may be a predictive factor of psychomotor development during the first Year of life irrespective of other variables related to treatment.

Wasniewska M, De Luca F, Cassio A, Oggiaro N, Gianino P, Delvecchio M, Aiazzi R, Stoppioni V, Lombardo F, Messina MF, Valenzise M, Arrigo T. Wasniewska M, et al. Eur J Endocrinol. 2003 Jul;149(1):1-6. doi: 10.1530/eje.0.1490001. Eur J Endocrinol. 2003. PMID: 12824859

10

Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia.

Lombardo F, De Luca F, Rosano M, Sferlazzas C, Lucanto C, Arrigo T, Messina MF, Crisafulli G, Wasniewska M, Valenzise M, Cucinotta D. Lombardo F, et al. Eur J Endocrinol. 2003 Jul;149(1):53-9. doi: 10.1530/eje.0.1490053. Eur J Endocrinol. 2003. PMID: 12824866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page